Join ACTA and a panel of experts, including researchers and consumers, on 28 July 2021 (11-12pm AEST) as we share our work on applying a simplified (integrated) consent approach in the context of low-risk clinical trials. We will discuss why a one-size-fits-all approach to obtaining clinical trial consent presents challenges, particularly for low-risk, pragmatic comparative effectiveness trials.
The webinar aims to:
- Increase awareness of the feasibility of applying proportionate consent approaches to low-risk comparative effectiveness research within the existing Australian regulatory and ethical framework.
- Describe when simplified (integrated) approaches may be appropriate.
- Describe the value of working in partnership with consumers to help design and implement proportionate approaches to consent for low-risk, comparative effectiveness research.
As proportionate (risk-based) consent approaches are established in other regions, ACTA commissioned a feasibility report that examined international best practice and the use of more flexible approaches to consent. Importantly, these approaches are already supported by the National Statement. ACTA has published a discussion paper that provides advice on simplified consent for low-risk pragmatic trials, so that trial consent is more feasible at point-of-care.
We look forward to connecting with everyone to explore this topic, including how this resource is being implemented in practice.
Latest Resources
-
-
Case study: Networking and information were key in setting up NECST
-
Case study: How the Drug and Alcohol Clinical Research and Improvement Network (DACRIN) is enhancing consumer involvement in research
-
Recommendations to improve cultural and linguistic diversity in clinical trials
-
Development of the Consumer Involvement and Engagement Toolkit
-
A snapshot of consumer engagement in clinical trials in Australia
-
Normalising comparative effectiveness trials as clinical practice
-
HeSANDA initiative stakeholder consultation project – final report
-
HeSANDA initiative stakeholder consultation project – Executive Summary of key findings
-
ACTA Report on the feasibility of a proportionate approach for comparative effectiveness research in Australia
-
ACTA Integrated Consent User Guide and Template
-
ACTA Discussion Paper: integrated consent – a tiered approach to consent for comparative effectiveness trials
-
HeSANDA Stakeholder Consultation Project
-
Consumer involvement in clinical trials: ethics committee members and research governance personnel training webinar – an overview
-
ACTA Comparative Effectiveness Trials: Requirements for Low Risk Ethics Review
-
Applying a proportionate approach to consent in comparative effectiveness trials
-
Consumers in Clinical Trials: Jenny Lam
-
Consumers in Clinical Trials: Zy Phillips
-
Consumers in Clinical Trials: Mitch Messer
-
ACTA Clinical Trial Diversity: CALD project
-
Consumer Involvement and Engagement Toolkit
-
What is randomisation?
-
What are clinical trials?
-
Consumer Involvement Consultation Report
-
International Best Practice Towards a Learning Healthcare System
-
How can clinical trials networks drive better translation of evidence into better quality care?
-
How can clinical trials networks drive better translation of evidence into better quality care?
-
The Clinician Researcher’s Perspective: Measuring impact on individual clinical practice
-
The Health Consumer’s Perspective: Now and in the next five years
-
Health system sustainability and continuous self-improvement
-
The Health Service Provider’s Perspective: How should we measure impact on service delivery?
-
Report on the Activities and Achievements of Clinical Trials Networks in Australia 2004-2014